500 related articles for article (PubMed ID: 26410689)
1. Development of Human Membrane Transporters: Drug Disposition and Pharmacogenetics.
Mooij MG; Nies AT; Knibbe CA; Schaeffeler E; Tibboel D; Schwab M; de Wildt SN
Clin Pharmacokinet; 2016 May; 55(5):507-24. PubMed ID: 26410689
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics of drug transporters in the enterohepatic circulation.
Stieger B; Meier PJ
Pharmacogenomics; 2011 May; 12(5):611-31. PubMed ID: 21619426
[TBL] [Abstract][Full Text] [Related]
3. Human Ontogeny of Drug Transporters: Review and Recommendations of the Pediatric Transporter Working Group.
Brouwer KL; Aleksunes LM; Brandys B; Giacoia GP; Knipp G; Lukacova V; Meibohm B; Nigam SK; Rieder M; de Wildt SN;
Clin Pharmacol Ther; 2015 Sep; 98(3):266-87. PubMed ID: 26088472
[TBL] [Abstract][Full Text] [Related]
4. Ontogeny of Hepatic Drug Transporters and Relevance to Drugs Used in Pediatrics.
Elmorsi Y; Barber J; Rostami-Hodjegan A
Drug Metab Dispos; 2016 Jul; 44(7):992-8. PubMed ID: 26712821
[TBL] [Abstract][Full Text] [Related]
5. Role of OATP transporters in the disposition of drugs.
Niemi M
Pharmacogenomics; 2007 Jul; 8(7):787-802. PubMed ID: 18240907
[TBL] [Abstract][Full Text] [Related]
6. Causes and Consequences of Variability in Drug Transporter Activity in Pediatric Drug Therapy.
Rodieux F; Gotta V; Pfister M; van den Anker JN
J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S173-92. PubMed ID: 27385174
[TBL] [Abstract][Full Text] [Related]
7. Pharmaceutical and pharmacological importance of peptide transporters.
Brandsch M; Knütter I; Bosse-Doenecke E
J Pharm Pharmacol; 2008 May; 60(5):543-85. PubMed ID: 18416933
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacogenetic implications of transmembrane transporters for the uptake, distribution and excretion of drugs].
Gerloff T; Roots I
Dtsch Med Wochenschr; 2003 Nov; 128(46):2431-6. PubMed ID: 14614658
[No Abstract] [Full Text] [Related]
9. Pharmacogenetics of membrane transporters: a review of current approaches.
Sissung TM; Gardner ER; Gao R; Figg WD
Methods Mol Biol; 2008; 448():41-62. PubMed ID: 18370230
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo approaches to characterize transporter-mediated disposition in drug discovery.
Feng B; Varma MV; Costales C; Zhang H; Tremaine L
Expert Opin Drug Discov; 2014 Aug; 9(8):873-90. PubMed ID: 24857286
[TBL] [Abstract][Full Text] [Related]
11. Impact of drug transporter pharmacogenomics on pharmacokinetic and pharmacodynamic variability - considerations for drug development.
Lai Y; Varma M; Feng B; Stephens JC; Kimoto E; El-Kattan A; Ichikawa K; Kikkawa H; Ono C; Suzuki A; Suzuki M; Yamamoto Y; Tremaine L
Expert Opin Drug Metab Toxicol; 2012 Jun; 8(6):723-43. PubMed ID: 22509796
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics of drug transporters.
Franke RM; Gardner ER; Sparreboom A
Curr Pharm Des; 2010; 16(2):220-30. PubMed ID: 19835554
[TBL] [Abstract][Full Text] [Related]
13. Expression, activity and pharmacokinetic impact of ocular transporters.
Vellonen KS; Hellinen L; Mannermaa E; Ruponen M; Urtti A; Kidron H
Adv Drug Deliv Rev; 2018 Feb; 126():3-22. PubMed ID: 29248478
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetics of membrane transporters: a review of current approaches.
Sissung TM; Goey AK; Ley AM; Strope JD; Figg WD
Methods Mol Biol; 2014; 1175():91-120. PubMed ID: 25150868
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetics/genomics of membrane transporters in cancer chemotherapy.
Huang Y
Cancer Metastasis Rev; 2007 Mar; 26(1):183-201. PubMed ID: 17323126
[TBL] [Abstract][Full Text] [Related]
16. Incorporating Ontogeny in Physiologically Based Pharmacokinetic Modeling to Improve Pediatric Drug Development: What We Know About Developmental Changes in Membrane Transporters.
Cheung KWK; van Groen BD; Burckart GJ; Zhang L; de Wildt SN; Huang SM
J Clin Pharmacol; 2019 Sep; 59 Suppl 1(Suppl 1):S56-S69. PubMed ID: 31502692
[TBL] [Abstract][Full Text] [Related]
17. Intestinal drug transporters: an overview.
Estudante M; Morais JG; Soveral G; Benet LZ
Adv Drug Deliv Rev; 2013 Oct; 65(10):1340-56. PubMed ID: 23041352
[TBL] [Abstract][Full Text] [Related]
18. Challenges and Opportunities for Increasing the Knowledge Base Related to Drug Biotransformation and Pharmacokinetics during Growth and Development.
Leeder JS; Meibohm B
Drug Metab Dispos; 2016 Jul; 44(7):916-23. PubMed ID: 27302933
[TBL] [Abstract][Full Text] [Related]
19. Implications of the dominant role of transporters in drug uptake by cells.
Dobson PD; Lanthaler K; Oliver SG; Kell DB
Curr Top Med Chem; 2009; 9(2):163-81. PubMed ID: 19200003
[TBL] [Abstract][Full Text] [Related]
20. Transporters and drug therapy: implications for drug disposition and disease.
Ho RH; Kim RB
Clin Pharmacol Ther; 2005 Sep; 78(3):260-77. PubMed ID: 16153397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
